Oxidant and antioxidant mechanisms of lung disease caused by asbestos fibres

European Respiratory Journal

Volumn 14, Issue 3, 1999, Pages 706-716

  Kinnula, V L ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

Antioxidant; Asbestos; Free radicals; Mesothelial; Mesothelioma; Superoxide dismutase

Indexed keywords

ANTIOXIDANT; ASBESTOS FIBER; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; DNA; GLUTATHIONE PEROXIDASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITROGEN DERIVATIVE; REACTIVE OXYGEN METABOLITE;

ANTIOXIDANT ACTIVITY; APOPTOSIS; CELL DAMAGE; CELL PROLIFERATION; INFLAMMATION; LUNG DISEASE; OXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0032882491     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.1999.14c35.x     Document Type: Review

References (136)

1. Mossman BT, Landesman JM. Importance of oxygen free radicals in asbestos-induced injury to airway epithelial cells. Chest 1983; 83: 50S-51S.
2. Mossman BT, Gee JBL. Medical progress: Asbestos-related diseases. N Engl J Med 1989; 320: 1721-1730.
3. Mossman BT, Bignon J, Corn M, Seaton A, Gee JBL. Asbestos: Scientific developments and implications for public policy. Science 1990; 247: 294-301.
4. Mossman BT, Marsh P. Evidence supporting a role for active oxygen species in asbestos-induced toxicity and lung disease. Environmental Health Perspect 1989; 81: 91-94.
5. Mossman BT, Kamp DW, Weitzman SA. Mechanisms of carcinogenesis and clinical features of asbestos-associated cancers. Cancer Invest 1996; 14: 466-480.
6. Goodglick LA, Kane AB. Cytotoxicity of long and short crocidolite asbestos-fibres in vitro and in vivo. Cancer Res 1990; 50: 5153-5163.
7. Kamp DW, Graceffa P, Pryor WA, Weitzman SA. The role of free radicals in asbestos-induced diseases. Free Radic Biol Med 1992; 12: 293-315.
8. Park SH, Aust AE. Regulation of nitric synthase induction by iron and glutathione in asbestos-treated human lung epithelial cells. Arch Biochem Biophys 1998; 360: 47-52.
9. Halliwell B, Gutteridge MC. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 1990; 186: 1-85.
10. Halliwell B, Gutteridge MC. Free radicals in biology and medicine, 3rd ed Oxford, Clarendon Press 1996.
11. Shatos MA, Doherty JM, Marsh JP, Mossman BT. Prevention of asbestos-induced cell death in rat lung fibroblasts and alveolar macrophages by scavengers of active oxygen species. Environmental Res 1987; 44: 103-116.
12. Weitzman SA, Graceffa P. Asbestos catalyzes hydroxyl and superoxide radical generation from hydrogen peroxide. Arch Biochem Biophys 1984; 228: 373-376.
13. Weitzman SA, Chester JF, Craceffa P. Binding of deferoxamine to asbestos in vitro and in vivo. Carcinogenesis 1988; 9: 1643-1645.
14. Lund LG, Aust AK. Iron-catalyzed reactions may be responsible for the biochemical and biological effects of asbestos. Bio Factors 1991; 3: 83-89.
15. Lund LG, Aust AE. Iron mobilization from crocidolite asbestos greatly enhances crocidolite-dependent formation of DNA single-strand breaks in X174 RFI DNA. Carcinogenesis 1992; 13: 637-642.
16. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol 1996; 271: C1424-C1437.
17. Molina YVL, McDonald B, Reep B, et al. Nitric oxide-induced s-nitrosylation of glyceraldehyde-3-phosphate dehydrogenase inhibits enzymatic activity and increase endogenous ADP-ribosylation. J Biol Chem 1992; 267: 24929-24943.
18. Zhu S, Manuel M, Tanaka S, Choe N, Kagan E, Matalon S. Contribution of reactive oxygen and nitrogen species to particulate-induced lung injury. Environ Health Perspect 1998; 106 (Suppl 5): 1157-1161.
19. Roney PL, Holian A. Possible mechanism of chrysotile asbestos - superoxide anion production in guinea-pig alveolar macrophages. Toxicol Appl Pharmacol 1989; 100: 132-144.
20. Sesko A, Capot M, Mossman B. Hydrolysis of inositol phospholipids precedes cellular proliferation in asbestos-stimulated tracheobronchial epithelial cells. Proc Natl Acad Sci 1990; 87: 7385-7389.
21. Perderiset M, Marsh JP, Mossman BT. Activation of protein kinase C by crocidolite asbestos in hamster epithelial cells. Carcinogenesis 1991; 12: 1499-1502.
22. Zanella CL, Posada J, Tritton TR, Mossman BT. Asbestos causes stimulation of the extracellular signal-regulated kinase 1 mitogen-activated protein kinase cascade after phosphorylation of the epidermal growth factor receptor. Cancer Research 1996; 56: 5334-5338.
23. Gulumian M, Van Wyk JA. Hydroxyl radical production in the presence of fibres by a Fenton-type reaction. Chem Biol Interact 1987; 62: 89-97.
24. Pezerat H, Zalmaa R, Guignard J, Jaurand MC. Production of oxygen radicals by the reduction of oxygen arising from the surface activity of mineral fibres. In: Bignon J, Peto J, Seracci R, eds. Non-occupational exposure to mineral fibres. JARC Scientific Publications 1989; 100-111.
25. Gabrielson EW, Rosen GM, Grafstrom RC, Strauss KE, Harris CC. Studies on the role of oxygen radicals on asbestos-induced cytopathology of cultured human lung mesothelial cells. Carcinogenesis 1986; 7: 1161-1164.
26. Kandaswami C, Morin G, Sirois P. Lipid peroxidation in rat macrophages exposed to chrysotile fibres. Toxicol in vitro 1988; 2: 117-120.
27. Goodglick LA, Pietras LA, Kane AB. Evaluation of the causal relationship between crocidolite asbestos-induced lipid peroxidation and toxicity to macrophages. Am Rev Respir Dis 1989; 139: 1265-1273.
28. Fontecave M, Mansuy D, Jaouen M, Pezerat H. The stimulatory effects of asbestos on NADPH-dependent lipid peroxidation in rat liver microsomes. Biochem J 1987; 241: 561-565.
29. Liochev SI, Fridovich I. Lucigenin as mediator of superoxide production: revisited. Free Radical Biol Med 1998; 25: 926-928.
30. Pola-Pleszczynski M, Rivest D, Bernardi M. Asbestos-induced chemiluminescence response of human polymorphonuclear leukocytes. Environmental Res 1984; 33: 1-6.
31. Hedenborg M, Klockars M. Production of reactive oxygen metabolites induced by asbestos fibres in human polymorphonuclear leukocytes. J Clin Pathol 1987; 40: 1189-1193.
32. Nyberg P, Klockars M. Measurement of reactive oxygen metabolises produced by human monocyte-derived macrophages exposed to mineral dusts. Int J Exp Pathol 1990; 71: 537-544.
33. Kinnula VL, Raivio KO, Linnainmaa K, Ekman A, Klockars MC. Neutrophil and asbestos fibre induced cytotoxicity in cultured human mesothelial and bronchial epithelial cells. Free Radic Biol Med 1995; 18: 391-399.
34. Ollikainen T, Linnainmaa K, Kinnula VL. DNA single strand breaks induced by asbestos fibres in human pleural mesothelial cells in vitro. Environ Mol Mutag 1999; 33: 178-185.
35. Thomas G, Ando T, Verma K, Kagan E. Asbestos fibres and interferon-γ up-regulate nitric oxide production in rat alveolar macrophages. Am J Respir Cell Mol Biol 1996; 11: 707-715.
36. Quinlan TR, BeruBe KA, Hacker MP, et al. Mechanisms of asbestos-induced nitric oxide production by rat alveolar macrophages in inhalation and in vitro models. Free Radic Biol Med 1998; 24: 778-788.
37. Tanaka S, Choe N, Hemenway DR, Matalon S, Kagan E. Asbestos inhalation induces reactive nitrogen species and nitrotyrosine formation in the lungs and pleura of the rat. J Clin Invest 1998; 102: 445-454.
38. Choe N, Tanaka S, Kagan E. Asbestos fibres and interleukin-1 upregulate the formation of reactive nitrogen species in rat pleural mesothelial cells. Am J Respir Cell Mol Biol 1998; 19: 226-236.
39. Kinnula VL, Aalto K, Raivio KO, Walles S, Linnainmaa K. Cytotoxicity of oxidants and asbestos fibres in cultured human mesothelial cells. Free Radic Biol Med 1994; 16: 169-176.
40. Kamp DW, Dunne M, Weitzman SA, Dunn MM. The interaction of asbestos and neutrophils injures cultured human pulmonary epithelial cells; Role of hydrogen peroxide. J Lab Clin Med 1989; 114: 604-612.
41. Kahlos K, Pitkänen S, Hassinen I, Linnainmaa K, Kinnula VL. Generation of reactive oxygen species. Br J Cancer 1999; 80: 25-31.
42. Kinnula VL, Pietarinen-Runtti P, Raivio KO, et al. Manganese superoxide dismutase in human pleural mesothelioma cell lines. Free Radic Biol Med 1996; 21: 527-532.
43. Kahlos K, Anttila S, Asikainen T, et al. Manganese superoxide dismutase in healthy human pleural mesothelium and in malignant pleural mesothelioma. Am J Respir Cell Mol Biol 1997; 18: 570-580.
44. Jackson JH, Schraufstatter IU, Hyslop PA, et al. Role of oxidants in DNA damage. J Clin Invest 1987; 80: 1090-1095.
45. Chen Q, Marsh J, Ames B, Mossman B. Detection of 8-oxo-2′-deoxyguanosine, a marker of oxidative DNA damage, in culture medium from human mesothelial cells exposed to crocidolite asbestos. Carcinogenesis 1996; 17: 2525-2527.
46. Chao CC, Park SH, Aust AE. Participation of nitric oxide and iron in the oxidation of DNA in asbestos-treated human lung epithelial cells. Arch Biochem Biophys 1996; 326: 152-157.
47. Turver CJ, Brown RC. The role of catalytic iron in asbestos induced lipid peroxidation and DNA-strand breakage in C3H10T 1/2 cells. Brit J Cancer 1987; 56: 133-136.
48. Libbus BL, Illenye SA, Craighead JE. Induction of DNA strand breaks in cultured rat embryo cells by crocidolite asbestos as assessed by nick translation. Cancer Res 1989; 49: 5713-5718.
49. Jaurand MC. Mechanisms of fibre-induced genotoxicity. Environ Health Perspectives 1997; 105: 1073-1084.
50. Lechner JF, Tokimwa T, LaVeck M, et al. Asbestos-associated chromosomal changes in human mesothelial cells. Proc Natl Acad Sci 1985; 82: 3884-3888.
51. Fung H, Kow YW, Van Houten B, Mossman BT. Patterns of 8-hydroxydeoxyguanosine formation in DNA and indications of oxidative stress in rat and human pleural mesothelial cells after exposure to crocidolite asbestos. Carcinogenesis 1997; 18: 825-832.
52. Ollikainen TRJ, Linnainmaa KI, Raivio KO, Kinnula VL. DNA single strand breaks and adenine nueleotide depletion as indices of oxidant effects on human lung cells. Free Radic Biol Med 1998; 24: 1088-1096.
53. Miyazaki Y, Araki K, Vesin C, Garcia I, Kapanci Y, Whitsett JA. Expression of a tumour necrosis factor-α transgene in murine lung causes lymphocytic and fibrosing alveolitis. J Clin Invest 1995; 96: 250-259.
54. Choe N, Tanaka S, Xia W, Hemenway DR, Roggli VL, Kagan E. Pleural maerophage recruitment and activation in asbestos-induced pleural injury. Environ Health Perspect 1997; 105 (Suppl 5): 1257-1260.
55. Granville DJ, Carthy CM, Hunt DWC, MeManus BM. Apoptosis: Molecular aspects of cell death and disease. Lab Invest 1998; 78: 893-911.
56. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281: 1309-1312.
57. BeruBe KA, Quinlan TR, Fung H, et al. Apoptosis is observed in mesothelial cells after exposure to crocidolite asbestos. Am J Respir Cell Mol Biol 1996; 15: 141-147.
58. Broaddus VC, Yang L, Scavo LM, Ernst JD, Boylan AM. Asbestos induces apoptosis of human and rabbit pleural mesothelial cells via reactive oxygen species. J Clin Invest 1996; 98: 2050-2059.
59. Hamilton RF, Li L, Iyer R, Holian A. Asbestos induces apoptosis in human alveolar macrophages. Am J Physiol 1996; 271: L813-L819.
60. Mossman BT, Churg A. Mechanisms in the pathogenesis of asbestosis and silicosis. Am J Respir Crit Care Med 1998; 157: 1666-1680.
61. Dong HY, Buard A, Levy F, Renier A, Laval F, Jaurand MC. Synthesis of poly(ADP-ribose) in asbestos treated rat pleural mesothelial cells in culture. Mutation Res 1995; 331: 197-204.
62. Broaddus VC, Yang L, Seavo LM, Ernst JD, Boylan AM. Crocidolite asbestos induces apoptosis of pleural mesothelial cells: Role of reactive oxygen species and poly(ADP-ribosyl)polymerase. Environ Health Perspect 1997; 105 (Suppl 5): 1147-1152.
63. Kane A, McDonald JL, Vaslet CA. Regulation of mesothelial cell proliferation in vitro and in vivo. In: Correlations Between in vitro and in vivo investigations in inhalation toxicology (U. Mohr, editor-in-chief) ILSI Monographs, ILSI Press, Washington, DC, pp. 163-171.
64. Goodgliek LA, Kane AB. Role of reactive oxygen metabolites in crocidolite asbestos toxicity to mouse macrophages. Cancer Res 1986; 46: 5558-5566.
65. Weitzman SA, Weitberg AB. Asbestos-catalyzed lipid peroxidation and its inhibition by desferroxamine. Biochem J 1985; 225: 259-262.
66. Churg A, Hobson J, Berean K, Wright J. Scavengers of active oxygen species prevent cigarette smoke-induced asbestos fibre penetration in rat tracheal explants. Am J Pathol 1989; 135: 599-603.
67. Mossman BT, Marsh JP, Shatos MA. Alteration of superoxide dismutase activity in tracheal epithelial cells by asbestos and inhibition of cytotoxicity by antioxidants. Lab Invest 1986; 54: 204-212.
68. Mossman BT, Marsh JP, Sesko A, et al. Inhibition of lung injury, inflammation, and interstitial pulmonary fibrosis bypolyethylene glycol-conjugated catalase in a rapid inhalation model of asbestosis. Am Rev Respir Dis 1990; 141: 1266-1271.
69. Mossman BT, Surinrut P, Brinton BT, et al. Transfection of a manganese-containing superoxide dismutase gene into hamster tracheal epithelial cells ameliorates asbestos-mediated cytotoxicity. Free Radic Biol Med 1996; 21: 125-131.
70. Kamp DW, Dunne M, Weitzman SA, Dunn MM. The interaction of asbestos and neutrophils injures cultured human pulmonary epithelial cells. Role of hydrogen peroxide. J Lab Clin Med 1989; 114: 604-612.
71. Janssen YM, Barchowsky A, Treadwell M, Driscoll KE, Mossman BT. Asbestos induces nuclear factor kappa B (NF-kappa B) DNA-binding activity and NF-kappa B-dependent gene expression in tracheal epithelial cells. Proc Nat Acad Sci 1995; 92: 8458-8462.
72. Janssen YM, Heintz NM, Marsh JP, Borm PJA, Mossman BT. Induction of c-fos and c-jun proto-oncogenes in target cells of the lung and pleura by carcinogenic fibres. Am J Respir Cell Mol Biol 1994; 11: 522-530.
73. Janssen YMW, Heintz NH, Mossman BT. Induction of c-fos and c-jun proto-oncogene expression by asbestos is ameliorated by n-Acetyl-l-Cysteine in mesothelial cells. Cancer Res 1995; 55: 2085-2089.
74. Janssen YMW, Marsh JP, Absher MP, et al. Oxidant stress responses in human pleural mesothelial cells exposed to asbestos. Am J Respir Crit Care Med 1994; 149: 795-802.
75. Janssen YMW, Marsh JP, Driscoll KE, Borm PJA, Oberdörster G, Mossman BT. Increased expression of manganese-containing superoxide dismutase in rat lungs after inhalation of inflammatory and fibrogenic minerals. Free Radic Biol Med 1994; 16: 315-322.
76. Quinlan TR, BeruBe KA, Marsh JP, et al. Patterns of inflammation, cell proliferation, and related gene expression in lung after inhalation of chrysotile asbestos. Am J Pathol 1995; 147: 728-739.
77. Arif JM, Ahmad I, Rahman Q. Chrysotile inhibits glutathione-dependent protection against the onset of lipid peroxidation in rat lung microsomes. Pharm Toxicol 1996; 79: 205-210.
78. Kamp DW, Dunne M, Anderson JA, Weitzman SA, Dunn MM. Neutrophils promote asbestos-induced injury to human pulmonary epithelial cells. J Lab Clin Med 1990; 116: 289-297.
79. Crapo JD, Tierney DF. Superoxide dismutase and pulmonary oxygen toxicity. Am J Physiol 1974; 226: 1401-1407.
80. Clerch LB, Massaro D. Tolerance of rats to hyperoxia. Lung antioxidant enzyme gene expression. J Clin Invest 1993; 91: 499-508.
81. Fridovich I, Freeman B. Antioxidant defences in the lung. Annu Rev Physiol 1986; 48: 693-702.
82. Oury TD, Chang L-Y, Marklund SL, Day BJ, Crapo JD. Immunocytochemical localization of extracellular superoxide dismutase in human lung. Lab Invest 1994; 70: 889-898.
83. Coursin DB, Cihla HP, Semph J, Oberley TD, Oberley LW. An immunohistochemical analysis of antioxidant and glutathione s-transferase enzyme levels in normal and neoplastic human lung. Histol Histopathol 1996; 11: 851-860.
84. Avissar N, Whitin JC, Allen PZ, Wagner DD, Liegey P, Cohen HJ. Plasma selenium-dependent glutathione peroxidase. Cell of origin and secretion. J Biol Chem 1989; 264: 15850-15855.
85. Awasthi YC, Sharma R, Singhal SS. Human glutathione S-transferases. Int J Biochem 1994; 26: 295-308.
86. Cantin AM, Fells GA, Hubbard RC, Crystal RG. Anti-oxidant macromolecules in the epithelial lining fluid of the normal human lower respiratory tract. J Clin Invest 1990; 86: 962-971.
87. Cantin AM, North SL, Hubbard RC, Crystal RG. Normal alveolar epthelial lining fluid contains high levels of glutathione. J Appl Physiol 1987; 63: 152-157.
88. Wong GH, Goeddel DV. Induction of manganous superoxide dismutase by tumour necrosis factor: possible protective mechanism. Science 1988; 242: 941-944.
89. Wong GH, Elwell JH, Oberley LW, Goeddel DV. Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumour necrosis factor. Cell 1989; 58: 923-931.
90. White CW, Ghezzi P, McMahon S, Dinarello CA, Repine JE. Cytokines increase rat lung antioxidant enzymes during exposure to hyperoxia. J Appl Physiol 1989; 66: 1003-1007.
91. Kawaguchi T, Takeyaseu K, Matsunobu T, et al. Stimulation of Mn-superoxide dismutase expression by tumour necrosis factor-alpha: quantitative determination of Mn-SOD protein levels in TNF-resistant and sensitive cells by ELlSA. Biochem Biophys Res Commun 1990; 171: 1378-1386.
92. Visner GA, Dougall WC, Wilson JM, Burr IA, Nick HS. Regulation of manganese superoxide dismutase by lipopolysaccharide, interleukin-1 and tumour necrosis factor. Role in the acute inflammatory response. J Biol Chem 1990; 265: 2856-2864.
93. Harris CA, Derbin KS, Hunte-McDonough B, et al. Manganese superoxide dismutase is induced by IFN-gamma in multiple cell types. Synergistic induction by IFN-gamma and tumour necrosis factor or IL-1. J Immunol 1991; 147: 149-154.
94. Warner BB, Burhans MS, Clark JC, Wispe JR. Tumour necrosis factor-alpha increases Mn-SOD expression: protection against oxidant injury. Am J Physiol 1991; 260: L296-L301.
95. Warner BB, Stuart L, Gebb G, Wispe J. Redox regulation of manganese superoxide dismutase. Am J Physiol 1996; 271: L150-L158.
96. 2 tolerance. Am J Physiol 1992; 263: L22-L26.
97. Forman HJ, Fisher AB. Antioxidant enzymes of rat granular pneumocytes. Constitutive levels and effect of hyperoxia. Lab Invest 1981; 45: 1-6.
98. Freeman BA, Mason RJ, Williams MC, Crapo JD. Anti-oxidant enzyme activity in alveolar type 11 cells after exposure of rats to hyperoxia. Exp Lung Res 1986; 10: 203-222.
99. 2 tension. Am J Physiol 1992; 262: L235-L241.
100. Chang LY, Kang BH, Slot JW, Vincent R, Crapo JD. Immunocytochemical localization of the sites of superoxide dismutase induction by hyperoxia in rat lungs. Lab Invest 1995; 73: 29-39.
101. Ho YS, Dey MS, Crapo JD. Antioxidant enzyme expression in rat lungs during hyperoxia. Am J Physiol 1996; 270: L810-L818.
102. Kinnula VL, Pietarinen P, Aalto K, Virtanen I, Raivio KO. Mitochondrial superoxide dismutase induction does not protect epithelial cells during oxidant exposure in vitro. Am J Physiol 1995; 268: L71-77.
103. Pietarinen-Runtti P, Raivio KO, Saksela M, Asikainen T, Kinnula VL. Antioxidant enzyme regulation and resistance to oxidants of human bronchial epithelial cells cultured under hyperoxic conditions. Am J Respir Cell Mol Biol 1998; 19: 286-292.
104. 2. J Appl Physiol 1993; 75: 1256-1262.
105. Janssen YM, van Houten B, Borm PJA, Mossman BT. Biology of disease. Cell and tissue responses to oxidative damage. Lab Invest 1993; 69: 261-274.
106. Pietarinen-Runtti P, Raivio KO, Linnainmaa K, Ekman A, Saksela M, Kinnula VL. Differential effects of tumour necrosis factor and asbestos fibres on manganese superoxide dismutase induction and oxidant-induced cytotoxicity in human mesothelial cells. Cell Biol Toxicol 1996; 12: 167-175.
107. Kinnula VL, Crapo JD, Raivio KO. Generation and disposal of reactive oxygen metabolises in the lung. Lab Invest 1995; 73: 3-19.
108. Tew KD. Glutathione-associated enzymes in anticancer drug resistance. Cancer Res 1994; 54: 4313-4320.
109. Hirvonen A, Pelin K, Tammilehto L, Karjalainen A, Mattson K, Linnainmaa K. Inherited GSTM1 and NAT2 defects as concurrent risk modifiers in asbestos-related human malignant mesothelioma. Cancer Res 1995; 55: 2981-2983.
110. Hirvonen A, Saarikoski ST, Linnainmaa K, et al. Glutatione s-Transferase and N-Acetyltransferase genotypes and asbestos-associated pulmonary disorders. J Natl Cancer Inst 1996; 88: 1853-1856.
111. Anttila S, Hirvonen A, Hysgafvel-Pursiainen K, Karjalainen A, Nurminen T, Vainio H. Combined effect of CYP1A1 inducibility and CSTM1 polymorphism on histological type of lung cancer. Carcinogenesis 1994; 15: 1133-1135.
112. Sun Y. Free radicals, antioxidant enzymes and carcinogenesis. Free Radic Biol Med 1990; 8: 583-599.
113. Oberley LW, Buettner GR. Role of superoxide dismutase in cancer: a review. Cancer Res 1979; 39: 1141-1149.
114. Church SL, Grant JW, Ridnour LA, et al. Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells. Proc Natl Acad Sci 1993; 90: 3113-3117.
115. Li J-J, Oberley LW, St Clair DK, Ridnour LA, Oberley TD. Phenotypic changes induced in human breast cancer cells by overexpression of manganese-containing superoxide dismutase. Oncogene 1995; 10: 1989-2000.
116. Cobbs CS, Levi DS, Aldape K, Israel M. Manganese superoxide dismutase expression in human central nervous system tumours. Cancer Res 1996; 56: 3192-3195.
117. Landriscina M, Remiddi F, Ria F, et al. The level of MnSOD is directly correlated with grade of brain tumours of neuroopithelial origin. Br J Cancer 1996; 74: 1877-1885.
118. Nishida S, Akai F, Iwasaki H, et al. Manganese superoxide dismutase content and localization in human thyroid tumours. J Pathol 1993; 169: 341-345.
119. Janssen AML, Bosman CB, Sier CFM, et al. Br J Cancer 1998; 78: 1051-1057.
120. Wispe JR, Warner BB, Clark JC, et al. Human Mn-superoxide dismutase in pulmonary epithelial cells of transgenic confers protection from oxygen injury. J Biol Chem 1992; 267: 23937-23941.
121. Das KC, White CW. Activation of NF-κB by antineoplastic agents. J Biol Chem 1997; 272: 14914-14920.
122. Das KC, Guo XI, White VW. Protein kinase cdelta-dependent induction of manganese superoxide dismutase gene expression by microtubule-active anticancer drugs. J Biol Chem 1999; 273: 34639-34645.
123. Ho Y-S, Vincent R, Rey MS, Slot JW, Crapo JD. Transgenic models for the study of lung antioxidant defense: Enhanced manganese-containing superoxide dismutase activity gives partial protection to B6C3 hybrid mice exposed to hyperoxia. Am J Respir Cell Mol Biol 1998; 18: 538-547.
124. De Haan JB, Cristiano F, Iannello R, Bladier C, Keiner MJ, Kola I. Elevation of the ratio of Cu/Zn-superoxide dismutase to glutathione peroxidase activity induces features of cellular senescence and this effect is mediated by hydrogen peroxide. Human Mol Gen 1996; 5: 283-292.
125. Nelson SK, Bose SK, McCord JM. The toxicity of highdose superoxide dismutase suggests that superoxide can both initiate and terminate lipid peroxidation in the reperfused heart. Free Radic Biol Med 1994; 16: 195-200.
126. Kinnula VL, Chang L, Everitt JI, Crapo JD. Oxidants and antioxidants in alveolar epithelial type II cells: in situ, freshly isolated and cultured cells. Am J Physiol 1992; 262: L69-L77.
127. Kinnula VL, Whorton AWR, Chang LY, Crapo JD. Regulation of hydrogen peroxide generation in cultured endothelial cells. Am J Respir Cell Mol Biol 1992; 175-182.
128. Kinnula VL, Everitt JI, Mangum JB, Chang LY, Crapo JD. Antioxidant defense mechanisms in cultured pleural mesothelial cells. Am J Respir Cell Mol Biol 1992; 7: 95-103.
129. Kinnula VL, Yankaskas JR, Chang L, Virtanen I, Linnala A, Crapo JD. Primary and immortalized (BEAS 2B) human bronchial epithelial cells have significant antioxidative capacity in vitro. Am J Respir Cell Mol Biol 1994; 11: 568-576.
130. Pietarinen P, Raivio K, Devlin B, Crapo JD, Chang LY, Kinnula VL. Catalase and glutathione reductase protection of alveolar macrophages in vitro. Am J Respir Cell Mol Biol 1995; 13: 434-441.
131. Narasimhan SR, Yang L, Gerwin BI, Broaddus VC. Resistance of pleural mesothelioma cell lines to apoptosis: relation to expression of Bcl-2 and Bax. Am J Physiol 1998; 275: L165-L171.
132. Kinnula K, Linnainmaa K, Raivio KO, Kinnula VL. Endogenous antioxidant enzymes and glutathione-S-transferase in protection of mesothelioma cells against hydrogen peroxide and epirubicin toxity. Br J Cancer 1998; 77: 1097-1102.
133. Zhang K, Mack P, Wong KP. Glutathione-related mechanisms in cellular resistance to anticancer drugs (Review). Int J Oncol 1998; 12: 871-882.
134. Segers K, Kumar-Singh S, Weyler J, et al. Glutathione S-transferase expression in malignant mesothelioma and non- neoplastic mesothelium: an immunohistochemical study. Cancer Res J Clin Oncol 1996; 122: 619-624.
135. Bailey HH, Gipp JJ, Ripple M, Wilding G, Mulccahu T. Increase in γ-glutamylcysteine synthetase activity and steady state messenger RNA levels in melphalan-resistant DU-145 human prostate carcinoma cells expressing elevated glutathione levels. Cancer Res 1992; 52: 5115-5118.
136. Ogretmen B, Bahadori HR, McCauley MD, Boylan A, Green MR, Safa AR. Co-ordinated over-expression of the MRP and γ-glutamylcysteine synthetase genes, but not MDR1, correlates with doxorubicin resistance in human malignant mesothelioma cell lines. Int J Cancer 1998; 75: 757-761.